Stakeholders Should Discuss Novartis’ Responsibility in the Promotion of Diovan, Large Sales: JMA Vice President

Satoshi Imamura, Vice President, Japan Medical Association Japan Medical Association (JMA) Vice President Satoshi Imamura said insurers and patient groups should be involved in discussing Novartis Pharma’s responsibility in promoting Diovan (valsartan) by using manipulated data, and scoring substantial sales,...read more